> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Lillis Foundation Asks C. Difficile Treatment Actions
- URL: https://www.fdaweb.com/lillis-foundation-asks-c-difficile-treatment-actions/
- Published: 2021-01-20T12:00:00.000Z
- Updated: 2026-09-14T16:43:32.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5148487

The Peggy Lillis Foundation for C. Diff Education and Advocacy is asking FDA to take several actions to improve the availability of microbiome treatments for *C. difficile* infections. The 1/12 [petition](https://www.regulations.gov/contentStreamer?documentId=FDA-2021-P-0084-0001&attachmentNumber=1&contentType=pdf&ref=fdaweb.com) asks FDA to: 

- engage patients and caregivers in developing agency guidelines for potential new therapies for *C. difficile*, including fecal-derived microbiota transplantation (FMT);
- finalize existing guidance for conventional FMT that includes a plan for its use once one or more microbiome therapies is approved and accessible;
- commit to greater transparency; and
- create a stool bank registry akin to tissue and blood banks.